LCLN Stock Analysis: Lincoln International | NYSE

Capital Markets | NYSE, USA | Market Cap: 2.474m USD | 12M Return: 12.9% | US5337141015 | Charts, Fundamentals & Technical Analysis

Investment Banking, Valuations, Restructuring, Private Funds
Total Rating 40
Safety 16
Buy Signal 0.59
Capital Markets
Industry Rotation: -19.6
Market Cap: 2.47B
Avg Turnover: 6.05M
Risk 3d forecast
Volatility36.5%
VaR 5th Pctl6.54%
VaR vs Median8.73%
Reward TTM
Sharpe Ratio0.83
Rel. Str. IBD81.2
Rel. Str. Peer Group89.4 pctl
Character TTM
Beta-0.357
Beta Downside-0.441
Hurst Exponent0.500
Choppyness58.5%
Drawdowns 3y
Max DD17.75%
CAGR/Max DD2.12
CAGR/Mean DD5.34
EPS (Earnings per Share) EPS (Earnings per Share) of LCLN over the last years for every Quarter: "2021-12": null, "2023-12": null, "2024-12": null, "2025-03": null, "2025-06": null, "2025-12": null, "2026-03": 0.0189, "2026-06": 0.26,
Qual. Beats: 0
Revenue Revenue of LCLN over the last years for every Quarter: 2021-12: 640.652, 2023-12: 518.331, 2024-12: 578.747, 2025-03: 132.208, 2025-06: 149.658, 2025-12: 783.807, 2026-03: 157.8, 2026-06: 225.693,
Rev. CAGR: 22.97%
Rev. Trend: 96.6%
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

Idiosyncratic Leader
Confidence

Seasonality 0.3 years of data

Jan - -
Feb - -
Mar - -
Apr - -
May - -
Jun - -
Jul - -
Aug - -
Sep - -
Oct - -
Nov - -
Dec - -

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: LCLN Lincoln International

Lincoln International, Inc. (NYSE: LCLN) is an independent investment banking advisory firm headquartered in Chicago, Illinois, founded in 1996 with operations across the United States, Europe, and Asia. The firm conducts its business through two core segments: Investment Banking Advisory and Valuations and Opinions.

The Investment Banking Advisory segment delivers capital advisory services-including debt advisory, special situations and restructuring, and growth/minority equity-alongside private funds advisory covering structured/continuation vehicles, single asset vehicles, primary funds, and co-investment vehicles. The Valuations and Opinions segment provides portfolio valuations, transaction opinions, board advisory, and disputes advisory services to a diverse institutional client base spanning private equity firms, private credit firms, mutual funds, insurance companies, banks, infrastructure firms, hedge funds, and other institutional investors.

In addition to transaction-related advisory, Lincoln International provides financial counsel to general partners, boards of directors, special committees, investors, trustees, and corporate decision-makers at both public and private companies. Complementary offerings include strategic consulting, an executive peer exchange called Connect (focused on leaders in insurance and wealth), an agency member network, and FirstChoice-a platform providing members with direct insurance carrier access, strategic business planning, technology services, and education.

The firm serves clients across Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology sectors. As an independent advisory firm, Lincoln International operates in the global investment banking sector, generating revenue primarily through advisory fees on M&A, capital structure, and valuation engagements rather than through principal investing or trading activities, and competes alongside both large universal banks and specialized boutique advisory firms.

Headlines to Watch Out For
  • M&A deal volume drives Investment Banking Advisory revenue
  • Private equity fundraising cycle boosts Valuations and Opinions demand
  • Higher interest rates pressure leveraged buyout deal pipeline
Piotroski VR-10 (Strict) 4.0
Net Income: 37.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.18 > 0.02 and ΔFCF/TA -4.26 > 1.0
NWC/Revenue: 31.35% < 20% (prev 60.01%; Δ -28.66% < -1%)
CFO/TA 0.18 > 3% & CFO 183.1m > Net Income 37.4m
Net Debt (131.1m) to EBITDA (95.7m): 1.37 < 3
Current Ratio: 2.41 > 1.5 & < 3
Outstanding Shares: last fiscal year (102.0m) vs prev -1.57% < -2%
Gross Margin: 42.44% > 18% (prev 69.81%; Δ -27.38% > 0.5%)
Asset Turnover: 81.24% > 50% (prev 90.41%; Δ -9.16% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM)
Altman Z'' 2.00
A: 0.21 (Total Current Assets 356.4m - Total Current Liabilities 147.9m) / Total Assets 997.8m
B: 0.00 (Retained Earnings 455k / Total Assets 997.8m)
C: 0.04 (EBIT TTM 35.6m / Avg Total Assets 819.0m)
D: 0.32 (Book Value of Equity 179.5m / Total Liabilities 560.5m)
Altman-Z'' = 2.00 = BBB
Beneish M -1.39
DSRI: 0.67 (Receivables 105.8m/138.2m, Revenue 665.4m/578.7m)
GMI: 1.65 (GM 69.81% / 42.44%)
AQI: 3.09 (AQ_t 0.48 / AQ_t-1 0.15)
SGI: 1.15 (Revenue 665.4m / 578.7m)
TATA: -0.15 (NI 37.4m - CFO 183.1m) / TA 997.8m)
Beneish M = -1.39 (Cap -4..+1) = D
What is the price of LCLN shares?

As of November 04, 2026, the stock is trading at USD 25.95 with a total of 259,157 shares traded. Over the past week, the price has changed by +10.71%, over one month by +10.05%, over three months by +27.31% and over the past year by +12.89%.

Current recommended Stop Loss: 24.60 (which is 5.2% or 1.4 ATR below the current price).

Is LCLN a buy, sell or hold?

Lincoln International has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold LCLN.

  • StrongBuy: 2
  • Buy: 1
  • Hold: 4
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the LCLN price?
Analysts Target Price 27.1 4.3%
Lincoln International (LCLN) - Fundamental Data Overview as of 04 November 2026
Market Cap USD = 2.47b (2.47b USD * 1.0 USD.USD)
P/S = 2.8322
P/B = 6.7517
Revenue TTM = 665.4m USD
EBIT TTM = 35.6m USD
EBITDA TTM = 95.7m USD
Long Term Debt = 101.9m USD (from longTermDebt, last quarter)
Short Term Debt = 139.9m USD (from shortTermDebt, last quarter)
Debt = 381.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 139.9m
Net Debt = 131.1m USD (calculated: Debt 381.7m - CCE 250.6m)
Enterprise Value = 2.61b USD (2.47b + Debt 381.7m - CCE 250.6m)
 Interest Coverage Ratio = unknown (Ebit TTM 35.6m / Interest Expense TTM 0.0)
 EV/FCF = 14.73x (Enterprise Value 2.61b / FCF TTM 176.9m)
FCF Yield = 6.79% (FCF TTM 176.9m / Enterprise Value 2.61b)
FCF Margin = 26.58% (FCF TTM 176.9m / Revenue TTM 665.4m)
Net Margin = 5.62% (Net Income TTM 37.4m / Revenue TTM 665.4m)
Gross Margin = 42.44% ((Revenue TTM 665.4m - Cost of Revenue TTM 383.0m) / Revenue TTM)
Gross Margin QoQ = 13.22% (prev 70.83%)
Tobins Q-Ratio = 2.61 (Enterprise Value 2.61b / Total Assets 997.8m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 381.7m)
Taxrate = 4.90% (1.92m / 39.2m)
NOPAT = 33.9m (EBIT 35.6m * (1 - 4.90%))
Current Ratio = 2.41 (Total Current Assets 356.4m / Total Current Liabilities 147.9m)
Debt / Equity = 2.13 (Debt 381.7m / totalStockholderEquity, last quarter 179.5m)
Debt / EBITDA = 1.37 (Net Debt 131.1m / EBITDA 95.7m)
Debt / FCF = 0.74 (Net Debt 131.1m / FCF TTM 176.9m)
Total Stockholder Equity = 431.2m (last fiscal year from totalStockholderEquity)
RoA = 4.57% (Net Income 37.4m / Total Assets 997.8m)
RoE = 8.67% (Net Income TTM 37.4m / Total Stockholder Equity 431.2m)
RoCE = 6.68% (EBIT 35.6m / Capital Employed (Equity 431.2m + L.T.Debt 101.9m))
RoIC = 3.54% (NOPAT 33.9m / Invested Capital 956.5m)
WACC = 3.86% (E(2.47b)/V(2.86b) * Re(4.45%) + D(381.7m)/V(2.86b) * Rd(0.0%) * (1-Tc(0.05)))
Discount Rate = 4.45% (= CAPM, Blume Beta Adj.)
Shares (yearly) Correlation: 33.33 | Cagr: 286.1%
[DCF] Terminal Value 77.97% ; FCFF base≈162.4m ; Y1≈186.2m ; Y5≈274.0m
[DCF] Fair Price = 114.6 (EV 4.12b - Net Debt 131.1m = Equity 3.99b / Shares 34.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 96.55 | Revenue CAGR: 22.97% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.37 | Chg30d=+36.85% | Revisions=+70% | Analysts=7
EPS current Year (2026-12-31): EPS=1.34 | Chg30d=-1.47% | Revisions=-38% | GrowthEPS=+0.0% | GrowthRev=+28.2%
EPS next Year (2027-12-31): EPS=1.73 | Chg30d=-0.24% | Revisions=-12% | GrowthEPS=+29.6% | GrowthRev=+15.3%
[Analyst] Revisions Ratio: +15% (up=10, down=7)